Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223301
Status:
COMPLETED
Last Update Posted:
2013-04-22
First Post:
2005-09-19
Brief Title:
Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Organization Data
Organization:
University of Texas Southwestern Medical Center
Class:
OTHER
Study ID:
1103-716
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Texas Southwestern Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Elliot Frohman
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Texas Southwestern Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biogen | INDUSTRY |
| Roche Pharma AG | INDUSTRY |